|
MIER3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.59850000000817E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.81889999995022E-06 |
| Normal-vs-Stage2 |
2.920000E-01 |
| Normal-vs-Stage3 |
6.075500E-03 |
| Normal-vs-Stage4 |
3.049000E-01 |
| Stage1-vs-Stage2 |
2.835600E-01 |
| Stage1-vs-Stage3 |
8.573200E-01 |
| Stage1-vs-Stage4 |
3.204800E-01 |
| Stage2-vs-Stage3 |
4.761400E-01 |
| Stage2-vs-Stage4 |
9.182000E-01 |
| Stage3-vs-Stage4 |
3.939800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.9068000000354E-06 |
| Normal-vs-AfricanAmerican |
3.158100E-03 |
| Normal-vs-Asian |
1.108590E-01 |
| Caucasian-vs-AfricanAmerican |
7.556200E-01 |
| Caucasian-vs-Asian |
6.697400E-01 |
| AfricanAmerican-vs-Asian |
7.669000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.57029999950475E-07 |
| Normal-vs-Female |
1.242240E-01 |
| Male-vs-Female |
3.292500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.018300E-03 |
| Normal-vs-Extreme_Weight |
2.26849999995782E-06 |
| Normal-vs-Obese |
1.246360E-02 |
| Normal-vs-Extreme_Obese |
7.75250000000227E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.388000E-01 |
| Normal_Weight-vs-Obese |
6.102400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.157600E-01 |
| Extreme_Weight-vs-Obese |
1.494220E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.389600E-01 |
| Obese-vs-Extreme_Obese |
2.099200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.286180E-02 |
| Normal-vs-Age(41-60Yrs) |
7.622400E-03 |
| Normal-vs-Age(61-80Yrs) |
2.86410000049919E-07 |
| Normal-vs-Age(81-100Yrs) |
4.086200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.664600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.200000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.507000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.737650E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.921200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.826400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.70929999999881E-05 |
| Normal-VS-Type2 PRCC |
3.86039999999976E-06 |
| Normal-VS-KIRP CIMP |
9.920400E-02 |
| Normal-VS-Unclassified PRCC |
1.637400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.182800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.980200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.695000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.862200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.197600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.813000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.65889999964786E-07 |
| Normal-vs-N1 |
2.742200E-01 |
| Normal-vs-N2 |
1.899840E-01 |
| N0-vs-N1 |
2.305900E-02 |
| N0-vs-N2 |
3.460400E-01 |
| N1-vs-N2 |
8.269800E-01 |
|
|
